ResearcherShanghai Jiao Tong UniversityNo recent work listed
Ziyun Shen
Matched on ORCID iD 0000-0001-5013-8532; OpenAlex author ID A5057066043. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 20
2019: 1 paper · 2020: none · 2021: none · 2022: 2 papers · 2023: 3 papers
Papers 6
- Risk factors for and prognostic values of postoperative acute kidney injury after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: A retrospective… Co-author DOI 10.1002/cam4.5543↗
- Long-term outcomes of standard versus extended lymphadenectomy in pancreatoduodenectomy for pancreatic ductal adenocarcinoma: A Chinese multi-center prospectiv… Co-author DOI 10.1016/j.jare.2022.09.011↗
- The Impact of Additional Para-aortic Dissection During Pancreaticoduodenectomy for Resectable Pancreatic Cancer. Co-author DOI 10.1245/s10434-022-12700-z↗
- Clinical characteristics and surgical outcomes of resectable acinar cell carcinoma of the pancreas-propensity score matching analysis with pancreatic ductal ad… Co-author DOI 10.1016/j.ejso.2021.11.135↗
- Oncological outcomes of robotic pancreatectomy in patients with pancreatic cancer who receive adjuvant chemotherapy: A propensity score-matched retrospective c… First author DOI 10.1016/j.ijsu.2022.106801↗
- Accuracy of Nodal Positivity in Inadequate Lymphadenectomy in Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma: A Population Study Using the US SEE… First author DOI 10.3389/fonc.2019.01386↗
Closest collaborators
The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Xiaxing Deng · 6 shared papers, 2019–2023 · strength 0.98
- Paper Risk factors for and prognostic values of postoperative acute kidney injury after pancreaticoduodenectomy for pancreati… DOI 10.1002/cam4.5543↗
- Paper Long-term outcomes of standard versus extended lymphadenectomy in pancreatoduodenectomy for pancreatic ductal adenocarc… DOI 10.1016/j.jare.2022.09.011↗
- Paper The Impact of Additional Para-aortic Dissection During Pancreaticoduodenectomy for Resectable Pancreatic Cancer. DOI 10.1245/s10434-022-12700-z↗
- Baiyong Shen · 5 shared papers, 2019–2023 · strength 0.81
- Paper Risk factors for and prognostic values of postoperative acute kidney injury after pancreaticoduodenectomy for pancreati… DOI 10.1002/cam4.5543↗
- Paper Long-term outcomes of standard versus extended lymphadenectomy in pancreatoduodenectomy for pancreatic ductal adenocarc… DOI 10.1016/j.jare.2022.09.011↗
- Paper The Impact of Additional Para-aortic Dissection During Pancreaticoduodenectomy for Resectable Pancreatic Cancer. DOI 10.1245/s10434-022-12700-z↗
- Haoda Chen · 4 shared papers, 2022–2023 · strength 0.70
- Paper Risk factors for and prognostic values of postoperative acute kidney injury after pancreaticoduodenectomy for pancreati… DOI 10.1002/cam4.5543↗
- Paper The Impact of Additional Para-aortic Dissection During Pancreaticoduodenectomy for Resectable Pancreatic Cancer. DOI 10.1245/s10434-022-12700-z↗
- Paper Oncological outcomes of robotic pancreatectomy in patients with pancreatic cancer who receive adjuvant chemotherapy: A … DOI 10.1016/j.ijsu.2022.106801↗
- Chenghong Peng · 3 shared papers, 2022–2023 · strength 0.52
- Paper Long-term outcomes of standard versus extended lymphadenectomy in pancreatoduodenectomy for pancreatic ductal adenocarc… DOI 10.1016/j.jare.2022.09.011↗
- Paper The Impact of Additional Para-aortic Dissection During Pancreaticoduodenectomy for Resectable Pancreatic Cancer. DOI 10.1245/s10434-022-12700-z↗
- Paper Oncological outcomes of robotic pancreatectomy in patients with pancreatic cancer who receive adjuvant chemotherapy: A … DOI 10.1016/j.ijsu.2022.106801↗
- Yuanchi Weng · 3 shared papers, 2022–2023 · strength 0.49
- Paper The Impact of Additional Para-aortic Dissection During Pancreaticoduodenectomy for Resectable Pancreatic Cancer. DOI 10.1245/s10434-022-12700-z↗
- Paper Oncological outcomes of robotic pancreatectomy in patients with pancreatic cancer who receive adjuvant chemotherapy: A … DOI 10.1016/j.ijsu.2022.106801↗
- Paper Clinical characteristics and surgical outcomes of resectable acinar cell carcinoma of the pancreas-propensity score mat… DOI 10.1016/j.ejso.2021.11.135↗
- Weishen Wang · 3 shared papers, 2019–2023 · strength 0.42
- Paper The Impact of Additional Para-aortic Dissection During Pancreaticoduodenectomy for Resectable Pancreatic Cancer. DOI 10.1245/s10434-022-12700-z↗
- Paper Clinical characteristics and surgical outcomes of resectable acinar cell carcinoma of the pancreas-propensity score mat… DOI 10.1016/j.ejso.2021.11.135↗
- Paper Accuracy of Nodal Positivity in Inadequate Lymphadenectomy in Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcin… DOI 10.3389/fonc.2019.01386↗
- Yuchen Ji · 2 shared papers, 2023 · strength 0.38
- Paper Risk factors for and prognostic values of postoperative acute kidney injury after pancreaticoduodenectomy for pancreati… DOI 10.1002/cam4.5543↗
- Paper The Impact of Additional Para-aortic Dissection During Pancreaticoduodenectomy for Resectable Pancreatic Cancer. DOI 10.1245/s10434-022-12700-z↗
- Yiran Zhou · 2 shared papers, 2023 · strength 0.38
- Paper Risk factors for and prognostic values of postoperative acute kidney injury after pancreaticoduodenectomy for pancreati… DOI 10.1002/cam4.5543↗
- Paper The Impact of Additional Para-aortic Dissection During Pancreaticoduodenectomy for Resectable Pancreatic Cancer. DOI 10.1245/s10434-022-12700-z↗
- Shulin Zhao · 1 shared paper, 2023 · strength 0.20
- Weishen WANG · 1 shared paper, 2023 · strength 0.18
- Wenhui Lou · 1 shared paper, 2023 · strength 0.18
- Jun Zhang · 1 shared paper, 2023 · strength 0.17
- Georgios Gemenetzis · 1 shared paper, 2022 · strength 0.16
- Baiyong Shen · 1 shared paper, 2022 · strength 0.16
- Jiabin Jin · 1 shared paper, 2022 · strength 0.16
- Xinjing Wang · 1 shared paper, 2022 · strength 0.16
- Yu Jiang · 1 shared paper, 2019 · strength 0.09
- Ningzhen Fu · 1 shared paper, 2019 · strength 0.09
- Siyi Zou · 1 shared paper, 2019 · strength 0.09
- Hao Chen · 1 shared paper, 2019 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.